Recap: GSK Q4 Earnings

GSK GSK reported its Q4 earnings results on Wednesday, January 31, 2024 at 03:50 AM.

Here's what investors need to know about the announcement.

Earnings

GSK missed estimated earnings by 4.27%, reporting an EPS of $0.718 versus an estimate of $0.75.

Revenue was up $1.41 billion from the same period last year.

Past Earnings Performance

Last quarter the company beat on EPS by $0.2 which was followed by a 1.19% drop in the share price the next day.

Here's a look at GSK's past performance:

Quarter Q3 2023 Q2 2023 Q1 2023 Q4 2022
EPS Estimate 1.07 0.87 0.82 0.50
EPS Actual 1.27 0.97 0.90 0.61
Revenue Estimate 9.37B 8.97B 8.06B 8.91B
Revenue Actual 10.27B 8.97B 8.44B 8.65B

To track all earnings releases for GSK visit their earnings calendar here.

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Market News and Data brought to you by Benzinga APIs
Comments
Loading...
Date
ticker
name
Actual EPS
EPS Surprise
Actual Rev
Rev Surprise
Posted In: EarningsBZI-Recaps
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!